Chat with us, powered by LiveChat
KoreaTech Today - Korea's Leading Tech and Startup Media Platform
  • Topics
    • Naver
    • Kakao
    • Nexon
    • Netmarble
    • NCsoft
    • Samsung
    • Hyundai
    • SKT
    • LG
    • KT
    • Retail
    • Startup
    • Blockchain
    • government
No Result
View All Result
KoreaTech Today - Korea's Leading Tech and Startup Media Platform
No Result
View All Result
Home Biotech

SK Holdings Injects 8 Billion Won in Hummingbird Bioscience in Series B

 666 total views,  1 views today

KoreaTechToday Editor by KoreaTechToday Editor
PUBLISHED: May 11, 2020 UPDATED: May 11, 2020
in Biotech, Hummingbird Bioscience, Series Funding, SK, SK Holdings, South Korea
0
SK Holdings invests 8 billion won in Hummingbird Bioscience in Series B Funding round.
SK Holdings invests 8 billion won in Hummingbird Bioscience in Series B Funding round.

SK Holdings invests 8 billion won in Hummingbird Bioscience in Series B Funding round.

SK Holdings on Monday said that it injected 8 billion won ($6.5 million) in Hummingbird Bioscience to secure novel antibody-based medicine technology. The holding company of SK Group became the lead investor in the Singapore-based biotech firm’s 30.6 billion won ($25 million) “Series B” extension funding round.

Hummingbird Bioscience, established in 2015, was founded by former members of Sanofi, an international pharmaceutical company. The biotech company researches novel antibody-based therapeutics considered as immunoproteins that selectively targets and destroys malignant proteins. These particular proteins become the starting point for diseases and tumors.

To date, the recently concluded “Series B” funding round of 30.6 billion won ($25 million) brought Hummingbird Bioscience’s total capital to over 79.6 billion won ($65 million). The company raised funds through strategic partnerships and financing activities.

SK Holdings said that the Singaporean biotech firm with its Rational Antibody Discovery technology dramatically shortens the amount of time spent on research. The platform could predict the structure of a protein and accurately identify the optimal areas for binding within diseased cells.

In a statement, Piers Ingram, CEO and co-founder of Hummingbird Bioscience, believes that the company could deliver significant benefits for patients with its strong portfolio of promising new therapies. He added that with SK Holdings joining their investor base, the new funds would further advance and support the development of their lead programs.

Growing Biopharma Market

Hummingbird pledged to utilize the raised funds to strengthen the company’s research and development (R&D) capabilities.

Heritas Capital Management, a participant in the Series B Funding, said that supporting foremost innovative biotech companies that address patients’ needs remains a top priority, especially during the coronavirus pandemic.

Quoting EvaluatePharma, a market researcher, SK Holdings, said that the total biopharma market would grow from 298 trillion won ($243 billion) in 2018 to 475 trillion won ($388 billion) in 2024, a yearly average increase of 8 percent.

In 2017, SK Holdings injected 1.22 trillion won ($1 billion) in Eureka Midstream, an energy company located in the United States. Last year, the company invested in Harbour BioMed, a China-based bioventure.

SK Holdings said it would continue to strive to make strategic investments in the field of biopharma development. The company added that it would diversify its portfolio beyond memory chips and telecommunications.

What’s your thoughts?
+1
0
Upvote
+1
0
Clap
+1
0
Clap
+1
0
On fire
+1
0
Meh
+1
0
Clap
+1
0
Tags: $25 million8 billion wonantibodyBiosciencebiotechcapitalcoronavirusfundingHummingbirdSeries BSKSK Holdings

Related Posts

SK Holdings and SK E&S partners with Plug Power to expand Asia’s green hydrogen economy, establishing fuel cell and hydrogen energy infrastructures.
SK Holdings invests 8 billion won in Hummingbird Bioscience in Series B Funding round.
Energy

SK Partners with Plug Power to Expand Asia’s Green Hydrogen Economy

February 27, 2021
U.S.-based NeoImmuneTech (NIT) plans to raise around 96 billion won from IPO on the Korean Securities Dealers Automated Quotations (KOSDAQ) in March.
SK Holdings invests 8 billion won in Hummingbird Bioscience in Series B Funding round.
Medical

US-Based NeoImmuneTech Targets 96 Billion Won IPO in KOSDAQ

February 27, 2021
South Korea targets to lower green car costs in collaboration with various industries and sectors for achieving the country’s 2050 carbon-neutrality goals .
SK Holdings invests 8 billion won in Hummingbird Bioscience in Series B Funding round.
Automobile

South Korea Pushes Lower Green Car Costs for Carbon-Neutrality Goals

February 23, 2021
South Korea’s Ministry of Trade, Industry, and Energy partners with Hyundai, LG, KST, and Hyundai Glovis for eco-friendly EV battery leasing and reusing.
SK Holdings invests 8 billion won in Hummingbird Bioscience in Series B Funding round.
Battery

South Korea Partners with Hyundai, LG, KST for EV Battery Reuse

February 20, 2021
South Korea’s procurement agency Defense Acquisition Program Administration (DAPA) said it would provide $3.9 billion for defense R&D projects this year.
SK Holdings invests 8 billion won in Hummingbird Bioscience in Series B Funding round.
South Korea

South Korea Pledged 4.3 Trillion Won for Defense R&D Projects This Year

February 19, 2021
Photo shows SK Innovation's proposed EV battery plant in Georgia, US. / photo courtesy of SK Innovation
SK Holdings invests 8 billion won in Hummingbird Bioscience in Series B Funding round.
Energy

Georgia Governor Request Biden to Reconsider SK Innovation ITC Ruling

February 15, 2021

FREE NEWSLETTER

  • NAVER

  • Kakao

  • Nexon

  • Netmarble

  • Ncsoft

  • Samsung

  • Hyundai

  • SK

  • LG

  • KT

Trending posts

  • Top 8 South Korean Mobile MMORPG to Watch Out For in 2021

     334 total views,  3 views today

  • Best Korean Dramas To Watch This 2021

     225 total views,  3 views today

  • South Korea Launches Low-Carbon Bullet Train KTX-Eum

     243 total views,  1 views today

  • Hyundai Motor in Negotiation with Apple for Apple Car Production

     252 total views,  3 views today

  • South Korea Ranks First Place Worldwide in Bloomberg Innovation Index

     113 total views,  3 views today

  • South Korea To Invest $5.3 Bln on Science, ICT R&D in 2021

     200 total views,  1 views today

  • SoCar, RideFlux to Test Run Driverless Shuttle Service in Jeju Island

     198 total views,  2 views today

  • Hyundai Stops Diesel Engine Development, Unveils IONIQ 5 Teaser Images

     210 total views,  1 views today

  • Hyundai Revises Statement on Involvement with Apple Car Production

     247 total views,  3 views today

  • Doosan Mobility Introduce Hydrogen Fuel Cell-Powered Firefighting Robots

     83 total views,  1 views today

More from our network


  • ktd

  • atd

  • itd

  • ktt

  • kgd

  • kpp

  • ktp

  • kpoppost

  • ustechtimes
  • About Us
  • Account Page
  • application form
  • Cookie policy
  • Default Redirect Page
  • homepage
  • Login
  • login form
  • LogOut
  • Privacy Policy
  • Register
  • Reset Password
  • Sample Page
  • Subscription Plan
  • Terms of Use
  • test
  • test
  • testpage
  • TOS Page
  • Visitor Inside User Page

Copyright © 2020 KoreaTechToday | About Us | Terms of Use |Privacy Policy |Cookie Policy|Contact : [email protected] |

No Result
View All Result
  • About Us
  • Account Page
  • application form
  • Cookie policy
  • Default Redirect Page
  • homepage
  • Login
  • login form
  • LogOut
  • Privacy Policy
  • Register
  • Reset Password
  • Sample Page
  • Subscription Plan
  • Terms of Use
  • test
  • test
  • testpage
  • TOS Page
  • Visitor Inside User Page

Copyright © 2020 KoreaTechToday | About Us | Terms of Use |Privacy Policy |Cookie Policy|Contact : [email protected] |

Get the latest from the biggest tech companies in Korea straight to your email. Subscribe now!